<DOC>
	<DOCNO>NCT00641212</DOCNO>
	<brief_summary>The purpose study compare effect Rhinocort nasal spray placebo growth child perennial allergic rhinitis 12 month .</brief_summary>
	<brief_title>Children , Perennial Allergic Rhinitis ( PAR ) , l-t Growth</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>In opinion investigator , candidate treatment nasal steroid base history either ) inadequate control symptoms antihistamine , decongestant and/or immunotherapy , b ) prior successful treatment nasal steroid . A documented history least one year perennial allergic rhinitis . A positive response skin prick test perennial allergen must present subject 's environment . Height weight within normal limit . Any disease may affect growth Sexual development later Tanner stage I. Nasal candidiasis , rhinitis medicamentosa , acute chronic sinusitis , influenza , upper respiratory tract infection structural abnormality nose ( e.g. , septal deviation , nasal polyp ) symptomatic enough cause significant nasal obstruction judge investigator .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Allergic rhinitis</keyword>
	<keyword>Perennial allergic rhinitis</keyword>
	<keyword>Paediatric</keyword>
	<keyword>Growth</keyword>
	<keyword>budesonide</keyword>
	<keyword>Rhinocort AQUA</keyword>
</DOC>